Navigation Links
PDI, Inc. to Hold Fourth Quarter and Full Year 2012 Financial Results Conference Call on Thursday, March 7, 2013
Date:2/28/2013

PARSIPPANY, N.J., Feb. 28, 2013 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that it will release its fourth quarter and full year 2012 financial results on Wednesday, March 6, 2013 after the market close and host a conference call on Thursday, March 7, at 8:30 am Eastern time to discuss the results.Access information:Date:Thursday, March 7, 2013Time:8:30 am Eastern timeDial-in numbers:(866) 644-4654 (U.S. and Canada) or (706) 643-1203 Conference ID number:98411955Live web cast:www.pdi-inc.com, under "Investor Relations"The teleconference replay will be available three hours after completion through March 11, 2013 at (800) 585-8367 (U.S. and Canada) or (404) 537-3406. The replay pass code is 98411955. The archived web cast will be available for one year on the company's web site, www.pdi-inc.com, under "Investor Relations."

About PDI, Inc.PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at http://www.pdi-inc.com.


'/>"/>
SOURCE PDI, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
2. Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
3. BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends
4. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
5. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
6. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
7. Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
8. Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M
9. Cepheid Reports Fourth Quarter and Full Year 2011 Results
10. BioMed Realty Trust to Report 2011 Fourth Quarter and Year End Results
11. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 The New ... STEM industries, Black Data Processing Associates (BDPA), is hosting ... June 8, 2013. This all-day event will encourage students ... learn the ins and outs from many of the ... p.m. at the New Jersey Institute of Technology, the ...
(Date:5/23/2013)... Mass. , May 23, 2013 Pressure ... announced that the Company will host a teleconference to ... provide a business update. The teleconference information is provided ... 11:00 a.m. Eastern Daylight Time (EDT) Dial-in: ... ); (302) 607-2001 (Int,l) Passcode: VS22823 For ...
(Date:5/23/2013)... DIEGO , May 23, 2013  Verenium Corporation ... company focused on the development and commercialization of high-performance ... , Chief Financial Officer, will present at two upcoming ... Mr. Black will present at the Second Annual Marcum ... the Grand Hyatt Hotel in New York City.  The ...
(Date:5/23/2013)... Canada (PRWEB) May 23, 2013 ... it is critical to adhere to principles of ... (HSP). , Esteemed speaker Dr. Jeremy Lim, Fellow, ... audience: , ,     Understand the International ... Practice (GCP) and additional regulations for the conduction ...
Breaking Biology Technology:Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
... 24 Cylene Pharmaceuticals, Inc. announced today the ... their first-in-class, oral CK2 inhibitor CX-4945 in patients ... closing of a $12 million financing with participation ... (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly ...
... N.J. and BRUSSELS, Sept. 24 Tarsa Therapeutics, ... UGNE ) today reported preclinical data ... combination with other drugs in reducing the collagen ... presented at the 2010 Osteoarthritis Research Society International ...
... the past 40 years describing the intricate series of ... two, they still haven,t agreed on how the process ... now may be reconciled by a third theory being ... could provide insights into the initiation of disease, such ...
Cached Biology Technology:Cylene Initiates Phase I Trial in Multiple Myeloma With CX-4945 Inhibitor of CK2 and Closes Accompanying Financing 2Cylene Initiates Phase I Trial in Multiple Myeloma With CX-4945 Inhibitor of CK2 and Closes Accompanying Financing 3Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis 2Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis 3Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis 4Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis 5Genetic switch underlies noisy cell division 2
(Date:5/22/2013)... May 22, 2013 U.S. Forest Service scientists are ... with funding from the TKF Foundation, will examine how ... and individuals recover from tragedy. , The TKF Foundation ... six projects selected for grant funding. In addition to ... spaces in recovery and resiliency, the 3-year, $585,000 grant ...
(Date:5/22/2013)... investigators also conclude that the 20 percent reduction ... (LDCT) versus chest X-ray (CXR) screening previously reported ... experienced screening centers in the United States. , ... their patients about the benefits and risks of ... the New England Journal of Medicine ...
(Date:5/22/2013)... cell powered buses, including a team from Simon ... processes and bus membrane durability. , The team ... in the operating cycle of the bus on ... study, led by SFU graduate student Natalia MaCauley, ... Burnaby-based Ballard Power Systems and funded by Automotive ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Tests lead to doubling of fuel cell life 2
... Bioengineers at the University of California, Berkeley, have discovered ... detection of biomolecules, dynamic reactions in a single living ... by which organic and inorganic molecules absorb light, the ... bioengineering and director of UC Berkeley,s Biomolecular Nanotechnology Center, ...
... multi-national team of biologists has concluded that developmental evolution ... a study of different species of roundworms. The findings ... Current Biology. The leading author is Karin ... of Biology. The research team included NYU Biology Professor ...
... Adding another layer of competition to the mating ... reproductive system of female mammals can sense the presence ... uterine environment. This may be the molecular mechanism behind ... with several partners play a role in determining which ...
Cached Biology News:New technique captures chemical reactions in a single living cell at unprecedented resolution 2New technique captures chemical reactions in a single living cell at unprecedented resolution 3Evolution is deterministic, not random, biologists conclude from multi-species study 2New evidence for female control in reproduction 2New evidence for female control in reproduction 3
... 9(S)-HODE-d4 contains 4 deuterium atoms at the ... intended for use as an internal standard for ... spectrometry. 9(S)-HODE is produced by the lipoxygenation of ... has been detected in atherosclerotic plaques, as an ...
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
...
...
Biology Products: